Auris Medical Holding Ltd. (EARS) Social Stream

Auris Medical Holding Ltd. (EARS): $3.05

0.05 (-1.61%)

POWR Rating

Component Grades








Add EARS to Watchlist
Sign Up

Industry: Biotech




#377 of 495

in industry

Featured Post From StockTwits About EARS

$EARS so i have been wondering why SemaPhore wasn't officially announced despite being in company materials, and looking back into July presentation I think this snip may be why and it needs an official toxicity study before further press(oligophore has this already). just a guess in thinking NHP meaning nano hyalrunoic acid particles. i could be wrong about this but it's the best i can come up with. hoping we can get more information on this as our first CYTO news.

found a recent 2020 study covering broad HA uses, other studies as well show potential use for novel cancer therapies.

"Hyaluronic acid is one of the most attractive molecules in the field of developing anticancer drug delivery carriers and imaging agents due to its physicochemical properties that provide various benefits in drug delivery systems. "

"We expect that further research using HA will provide innovative results and insights into the development of novel cancer therapies."
niftybritches, published July 26, 2021

Loading social stream, please wait...

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from!